The Asia-Pacific transplant diagnostics market is forecasted to grow at a 9.35% CAGR from 2023 to 2028 and the market size is anticipated to grow from USD 1470 million by 2028 from USD 940.4 million in 2023.
The growing number of organ transplantation procedures across the countries of the Asia-Pacific region is one of the major factors driving the transplant diagnostics market in APAC. An expected 4,00,000 registered patients are waiting for a kidney transplant. Therefore, it is estimated the number of organ transplantation procedures in the APAC region is expected to grow significantly in the coming years owing to the growing number of organ failure cases in the countries of the APAC region. In addition, factors such as changes in lifestyle, such as increasing consumption of alcohol, smoking, junk foods, and lack of physical activity, are expected to result in a growing number of heart, liver, and kidney failure cases in the coming future across the APAC region. As a result, due to increasing awareness, people suffering from organ failure prefer to have a transplant, which requires a transplant diagnostic for the best treatment result, propelling the APAC transplant diagnostics market growth.
In addition, the rising number of organ donation camps and awareness programs across the APAC region is anticipated to boost the growth rate of the transplant diagnostics market in the APAC region. Furthermore, the growing adoption of technological developments in transplant diagnostics is expected to contribute to the regional market. Therefore, researchers and key market players are focusing more on developing effective medical devices used in transplantation procedures with the help of the latest technological developments to improve treatment, produce accurate results, and help patients undergo safe transplant procedures. In addition, researchers are focusing on manufacturing devices that check the compatibility of the donors organ in the receptor body by taking the receptor samples. Furthermore, increasing government and public and private investments will boost APAC market growth.
Increasing cases of organ rejection also demand the need to undergo transplant diagnostics, which is predicted to result in the growth of the transplant diagnostics market in the APAC region. Organ rejection is a significant challenge in organ transplantation and may lead to mortality in some cases. To reduce these cases, transplant diagnostics centers help check the organ before or after the transplantation procedures. Additionally, the increasing development of artificial organs also needs transplant diagnostics, favoring regional market growth.
However, the high costs associated with transplantation procedures and diagnostics hamper the regional market growth. In addition, factors such as the scarcity of skilled professionals, unfavorable reimbursement policies, and lack of proper healthcare infrastructure facilities in some countries of the APAC region are restraining regional market growth. Furthermore, the inaccurate result from the transplant diagnostic devices due to low-quality manufacturing impedes market growth.
This research report on the Asia-Pacific transplant diagnostics market has been segmented & sub-segmented into the following categories.
By Technology:
By Product:
By Application:
By Transplant Type:
By End-User:
By Country:
APAC is one of the promising regional markets for transplant diagnostics globally and is estimated to showcase a notable CAGR during the forecast period owing to the increasing number of organ donations and rising awareness regarding transplant diagnostics. The governments of APAC countries have conducted several programs to promote awareness regarding the usage of transplant diagnostics and their significance. The transplant diagnostic before or after the procedure helps increase the patient's life span with minor side effects.
The Indian market is anticipated to hold the most significant share of the APAC market during the forecast period owing to the increasing number of product launches and the establishment of diagnostics centers. For example, in 2020, a U.S.-based company named Plexision established a laboratory in India that provides a wide range of transplant tests for patients. They also test the rejection levels, viral infection, and genetic testing.
The Chinese market is estimated to occupy a considerable share of the worldwide market during the forecast period owing to the increasing number of transplant centers in China. More than 160 transplant centers are present in China, and the number is increasing due to the increasing adoption of transplant procedures among the population due to chronic diseases. As a result, transplant diagnostics centers also increased, which helped in the market growth.
During the forecast period, the Japanese market is predicted to witness a healthy CAGR in the APAC market. Increasing liver transplantation surgeries in Japan is one of the major factors driving the Japanese market growth. In addition, a growing number of R&D activities in Japanese transplant laboratories help manufacture advanced devices and software that help track the transplanted organ in the receptor body for better treatment.
KEY MARKET PLAYERS:
Companies such as CareDx, Pacific Biosciences of California, Illumina, Thermo Fischer Scientific, GenDx, and Immucor are notable companies in the APAC Transplant Diagnostics Market.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1400
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: sales@marketdataforecast.com
Reports By Region